16. ganesh jaiswal| Link |
Dec 7, 2021 12:16:03 PM
IPO Guru (1000+ Posts, 600+ Likes)
Regular customer of Medplus, they provide 20% on medicines above Rs 1000 bill and delivery time 2 to maximum 24 hours. Far better service than competitors like pharmeasy, Netmeds, 1mg. The same discount they are giving at offline stores.
- More and more 2nd rung hospitals opening inhouse chemist shops. - Many other local pharmacy chains stared offering equal discount. - brands prescribed by local doctors not available. may be sourcing city based requirement. local shop level purchase not allowed. many buyers refuse alternate brands offered .
16.2. PowerUser| Link |
Dec 8, 2021 10:12:50 AM
(200+ Posts)
Personally I like it too. But this is a volume business, low margins. Private labels will fetch more margins. Though more competition is coming up, lot more opportunity in india to grow this business. Established organized players will get bigger slice eventually. Long term story.
They do have Private labels in FMCG sector which they sell along with medicines
Personally i like their 20% discount on medicines plus Diagnostic services which are less costlier than established players( along with Home collection).
I dont talk about financials but they are trying to expand with medical and related things like Diagnostic services which should be +ve for company.
Though Hospital have inhouse chemists, people like me tend to buy where we will get better pricing.
You are right sir, but why suddenly profit ratio jumped before IPO. there are so many IPOs and you may have seen financial statements of them. All fraud companies are mostly offloading their equity at high rate and thereafter never seen much profit. How many companies with such operations are from good business families. None. because they believe in building trust and these type of new crop is interested for their own benefits.
15.5. K.Atar| Link |
Dec 7, 2021 9:54:29 PM
IPO Mentor (900+ Posts, 500+ Likes)
Taiyari toh karhi hi padti hai, sabhi log sidhe paytm se thodi hi na apply kar dete hain.
Many would look at financials Some will study it A few will research it.
Will see how is the response of the investor community for this IPO, overall not bad (on gmp indicator front), we can go for it though we have many alternatives for investing.
@ashok ji i meant for good financials @ J Rakesh i don''t feel so it''s just a co incident i know co. very well i m using it''s service since many year''s(almost 10 years). i feel no problem with co. @ k atar yup i just want to see final figures of subscription though still didn''t checked P/E n valuation will se n update that anything left on the table for listing gain or not....?
I think Medplus, C E Info (map my India), data patterns, euro panel (good but check you have 140000/- to apply this SME, I am still stuck in aashka hospital, heavy losses), are good to apply and I may apply these all.
12. sonal patel| Link |
Dec 7, 2021 9:47:52 PM
IPO Guru (1400+ Posts, 5500+ Likes)
Gmp of Medplus is 312 - 316 rs. Apply for listing gain..
11. bAAz| Link |
Dec 7, 2021 7:51:36 PM
IPO Mentor (500+ Posts, 300+ Likes)
as per axis bank analysis, their eps diluted is about 6 rs for year ending March 21 and 6 rs also for six month period ending sept 21. So, I guess PE based on annualised earning is right at 133 or 67 based on six monthly
9.3. gjy| Link |
Dec 7, 2021 6:30:09 PM
IPO Guru (1400+ Posts, 3300+ Likes)
yes , got it. Fv 10 v 2 checked with all March 2020 and March 2019 also
RHP
IPO Guru (1000+ Posts, 600+ Likes)
IPO Mentor (500+ Posts, 600+ Likes)
